Cordycepin, derived from fungi, shows promise in cancer therapy by inhibiting growth factor signaling pathways critical for ...

Q3 2024 Earnings Call Transcript November 14, 2024 Operator: Good afternoon, ladies and gentlemen, and welcome to the ...

Kura Oncology (KURA) reported preclinical data supporting the development of the Company’s menin inhibitor, ziftomenib, for the treatment ...

effectively silencing both the ERK and AKT/mTOR signaling pathways and driving robust cell cycle arrest and apoptosis. Given that imatinib is well established as the frontline standard of care in ...

THRAP3, STMN1, and GNA13—are overrepresented in blood cancers like acute myeloid leukemia (AML) and could prove to be novel ...

Combination of ziftomenib and imatinib shows robust and durable antitumor activity in imatinib-sensitive (1L) and imatinib-resistant (2L/3L) GIST models – – Proof-of-concept study of ziftomenib plus ...

Rapid-Lift Advanced Neck Serum is a beauty product from a trusted manufacturer that was specifically formulated to have a ...

We expect the nemolizumab, which targets IL-31 signaling involved in pruritus ... leading to constant activation of the PI3K, AKT, mTOR or PAM pathway promoting cancer cell proliferation and ...

We are also researching genetic and molecular markers for targeted treatment of LABC in New York women with the goal of translating the Akt/mTOR pathway to treatment ... We investigate hormone ...

Cancer remains one of the leading global causes of mortality, with an estimated increase in cases due to lifestyle, ...